DaVita Inc
NYSE:DVA
Intrinsic Value
DaVita, Inc. engages in the provision of medical care services. [ Read More ]
The intrinsic value of one DVA stock under the Base Case scenario is 192.62 USD. Compared to the current market price of 132.77 USD, DaVita Inc is Undervalued by 31%.
Valuation Backtest
DaVita Inc
Run backtest to discover the historical profit from buying and selling DVA stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
DaVita Inc
Current Assets | 3.1B |
Cash & Short-Term Investments | 391.7m |
Receivables | 2.4B |
Other Current Assets | 330.3m |
Non-Current Assets | 13.8B |
Long-Term Investments | 593.7m |
PP&E | 5.6B |
Intangibles | 7.3B |
Other Non-Current Assets | 271.3m |
Current Liabilities | 2.6B |
Accounts Payable | 514.5m |
Accrued Liabilities | 1.1B |
Other Current Liabilities | 980.7m |
Non-Current Liabilities | 13.2B |
Long-Term Debt | 8.3B |
Other Non-Current Liabilities | 4.9B |
Earnings Waterfall
DaVita Inc
Revenue
|
12.1B
USD
|
Cost of Revenue
|
-8.3B
USD
|
Gross Profit
|
3.8B
USD
|
Operating Expenses
|
-2.2B
USD
|
Operating Income
|
1.6B
USD
|
Other Expenses
|
-909.5m
USD
|
Net Income
|
691.5m
USD
|
Free Cash Flow Analysis
DaVita Inc
DVA Profitability Score
Profitability Due Diligence
DaVita Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
DaVita Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
DVA Solvency Score
Solvency Due Diligence
DaVita Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.
Score
DaVita Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DVA Price Targets Summary
DaVita Inc
According to Wall Street analysts, the average 1-year price target for DVA is 134.64 USD with a low forecast of 115.14 USD and a high forecast of 152.25 USD.
Ownership
DVA Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
DVA Price
DaVita Inc
Average Annual Return | 13.52% |
Standard Deviation of Annual Returns | 39.83% |
Max Drawdown | -25% |
Market Capitalization | 11.8B USD |
Shares Outstanding | 87 700 000 |
Percentage of Shares Shorted | 8.19% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 69,000 full-time employees. The firm's principal business is to provide dialysis and related lab services to patients. The company is engaged in providing care delivery, referred to as United States (U.S.) dialysis business. The firm also operate various ancillary services, including its international operations, as well as its corporate administrative support. Its U.S. dialysis business is a provider of kidney dialysis services for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD) or end stage kidney disease (ESKD). The firm's ancillary services consist primarily of integrated care and disease management, clinical research programs and physician services, as well as its international operations. The firm's international dialysis operations provides dialysis and administrative services through a total of 333 outpatient dialysis centers located in ten countries outside of the United States.
Contact
IPO
Employees
Officers
The intrinsic value of one DVA stock under the Base Case scenario is 192.62 USD.
Compared to the current market price of 132.77 USD, DaVita Inc is Undervalued by 31%.